Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

Medizinische Universitat Wien ( Site 0778), Vienna

Melanoma Institute Australia ( Site 0452), North Sydney

Westmead Hospital ( Site 0451), Westmead

Sandton Oncology Medical Group PTY LTD ( Site 0802), Johannesburg

Lismore Base Hospital ( Site 0453), Lismore

Eastern Health ( Site 0457), Box Hill

Universitaetsspital Basel ( Site 0094), Basel

Princess Alexandra Hospital ( Site 0454), Wooloongabba

Cancer Care Langenhoven Drive Oncology Centre ( Site 0805), Port Elizabeth

Fiona Stanley Hospital ( Site 0456), Murdoch

Kantonsspital Graubuenden ( Site 0091), Chur

Cape Town Oncology Trials Pty Ltd ( Site 0803), Kraaifontein

LKH Universitatsklinikum Graz ( Site 0776), Graz

Universitaetsspital Zuerich ( Site 0092), Zuerich-Flughafen

Kantonsspital Winterthur ( Site 0095), Winterthur

Hopital La Timone ( Site 0002), Marseille

Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 0182), A Coruña

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0064), Milan

Istituto Europeo di Oncologia ( Site 0067), Milan

CHU Dijon Bourgogne ( Site 0010), Dijon

Hautkrebszentrum Buxtehude ( Site 0037), Buxtehude

Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 0033), Kiel

ASST Papa Giovanni XXIII ( Site 0062), Bergamo

University of North Carolina - Cancer Hospital ( Site 0751), Chapel Hill

Hospital General Universitario Gregorio Maranon ( Site 0191), Madrid

Hospital Universitario Ramon y Cajal ( Site 0183), Madrid

Hospital Universitario La Paz ( Site 0184), Madrid

Hospital Universitario Carlos Haya ( Site 0186), Málaga

UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0704), San Francisco

Klinik fur Dermatologie Allergologie und Venerologie ( Site 0035), Hannover

Institut Claudius Regaud IUCT Oncopole ( Site 0003), Toulouse

Baptist MD Anderson Cancer Center ( Site 0767), Jacksonville

Mid-Florida Cancer Centers ( Site 0764), Orange City

Hospital Universitario Insular de Gran Canaria ( Site 0189), Las Palmas de Gran Canaria

Istituto Oncologico Veneto ( Site 0063), Padua

Hospital Universitario Marques de Valdecilla ( Site 0181), Santander

Kyungpook National University Chilgok Hospital ( Site 0553), Daegu

Azienda Ospedaliera Universitaria Senese ( Site 0065), Siena

Minnesota Oncology Specialist, PA ( Site 0766), Fridley

CHRU Lille - Hopital Claude Huriez ( Site 0004), Lille

St. Vincent Frontier Cancer Center ( Site 0724), Billings

AMG Oncology ( Site 0714), Park Ridge

Illinois Cancer Care, PC ( Site 0765), Peoria

Shamir Medical Center-Assaf Harofeh ( Site 0308), Ẕerifin

CHU de Rouen ( Site 0013), Rouen

University of Colorado Cancer Center ( Site 0708), Aurora

Istituto Nazionale Tumori Fondazione Pascale ( Site 0061), Napoli

CHU de la Miletrie Poitiers ( Site 0011), Poitiers

The Angeles Clinic and Research Institute ( Site 0707), Los Angeles

John Wayne Cancer Institute ( Site 0706), Santa Monica

Universitaetsklinikum Erlangen ( Site 0044), Erlangen

Hopital Ambroise Pare Boulogne ( Site 0007), Boulogne-Billancourt

California Pacific Medical Center Research Institute ( Site 0705), San Francisco

Institut Gustave Roussy ( Site 0001), Villejuif

Centre Hospitalier Victor Dupouy ( Site 0012), Argenteuil

Universitaetsklinikum Wuerzburg-Department of Dermatology ( Site 0036), Würzburg

OHSU Center for Health & Healing ( Site 0731), Portland

Beijing Cancer Hospital ( Site 0601), Beijing

The First Hospital Of Jilin University ( Site 0603), Changchun

Fudan University Shanghai Cancer Center ( Site 0607), Shanghai

Nanjing Drum Tower Hospital ( Site 0609), Nanjing

Tianjin Medical University Cancer Institute & Hospital ( Site 0606), Tianjin

Sir Run Run Shaw Hospital ( Site 0605), Hangzhou

Zhejiang Cancer Hospital ( Site 0608), Hangzhou

Fujian Provincial Cancer Hospital ( Site 0612), Fuzhou

Yunnan Cancer Hospital ( Site 0604), Kunming

Henan Cancer Hospital ( Site 0610), Zhengzhou

Sun Yat-Sen University Cancer Center ( Site 0602), Guangzhou

HaEmek Medical Center ( Site 0306), Afula

Oncocentro ( Site 0424), Viña del Mar

Rambam Medical Center ( Site 0301), Haifa

Centro Investigación del Cáncer James Lind ( Site 0425), Temuco

Rabin Medical Center ( Site 0302), Petah Tikva

Chaim Sheba Medical Center ( Site 0304), Ramat Gan

Sourasky Medical Center ( Site 0307), Tel Aviv

Fundacion Arturo Lopez Perez FALP ( Site 0421), Santiago

Pontificia Universidad Catolica de Chile ( Site 0422), Santiago

Sociedad Medica Aren y Bachero Limitada ( Site 0426), Santiago

Soroka Medical Center ( Site 0303), Beersheba

Hadassah Ein Karem Hebrew University Medical Center ( Site 0305), Jerusalem

Yale Cancer Center ( Site 0709), New Haven

Atlantic Health System ( Site 0768), Morristown

Valley Hospital ( Site 0749), Paramus

Inova Schar Cancer Institute ( Site 0739), Fairfax

PERSONAL - Oncologia de Precisao e Personalizada ( Site 0399), Belo Horizonte

Hospital de Caridade de Ijui ( Site 0391), Ijuí

Hospital Sao Vicente de Paulo ( Site 0396), Passo Fundo

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0397), Porto Alegre

Instituto Nacional de Cancer Hospital do Cancer II ( Site 0394), Rio de Janeiro

BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 0661), Kelowna

Lions Gate Hospital ( Site 0662), North Vancouver

Sunnybrook Research Institute ( Site 0654), Toronto

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0652), Montreal

McGill University Health Centre ( Site 0651), Montreal

Hopital ARCHET 2 ( Site 0009), Nice

Universitaetsklinikum Carl Gustav Carus ( Site 0041), Dresden

Universitaetsklinikum Leipzig ( Site 0040), Leipzig

SRH Wald-Klinikum Gera GmbH ( Site 0042), Gera

Szpital Kliniczny im. Heliodora Swiecickiego Uniwers Medyczn ( Site 0272), Poznan

Centrum Onkologii im.prof. F. Lukaszczyka w Bydgoszczy ( Site 0273), Bydgoszcz

Pratia MCM Krakow ( Site 0280), Krakow

Uniwersyteckie Centrum Kliniczne ( Site 0281), Gdansk

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 0278), Gliwice

Seoul National University Hospital ( Site 0554), Seoul

Severance Hospital Yonsei University Health System ( Site 0552), Seoul

Samsung Medical Center ( Site 0551), Seoul

Hospital Duran i Reinals ICO de Hospitalet ( Site 0187), Hospitalet Del Llobregat

Hospital Clinic i Provincial Barcelona ( Site 0190), Barcelona

Laenssjukhuset Ryhov ( Site 0215), Jönköping

Centrallasarettet Vaxjo ( Site 0214), Vaxjo

Skanes Universitetssjukhus ( Site 0213), Lund

Karolinska Universitetssjukhuset ( Site 0211), Solna

Akademiska Sjukhuset ( Site 0218), Uppsala

Norrlands Universitetssjukhus ( Site 0216), Umeå

Sahlgrenska Universitetssjukhuset ( Site 0212), Gothenburg

Western General Hospital ( Site 0121), Edinburgh

Guys and St Thomas NHS Foundation Trust ( Site 0126), London

Derriford Hospital ( Site 0129), Plymouth

Singleton Hospital ( Site 0131), Swansea